echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Cardiovasc diabetol: Relationship between the course of diabetes and mortality in hospitalized patients with acute myocardial infarction

    Cardiovasc diabetol: Relationship between the course of diabetes and mortality in hospitalized patients with acute myocardial infarction

    • Last Update: 2022-11-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Diabetes is associated with an increased risk of death in hospitalized patients with acute myocardial infarction (AMI); However, no studies investigated the effect of duration of
    diabetes on in-hospital mortality in people with AMI.

    Recently, a research article was published in Cardiovasc Diabetol, an authoritative journal in the field of cardiometabolic diseases, in which researchers assessed the in-hospital mortality rate
    of AMI patients based on the status and duration of diabetes in subjects.

    Using the Lombardy regional health management database, the researchers included hospitalized AMI patients over the age of 50 with diabetes between 2010 and 2019 and stratified them according to the duration of the diabetes course: < 5 years, 5-10 years, and > 10 years
    .
    The primary endpoint of the study was mortality during AMI hospitalization, and the secondary endpoint was 1-year mortality
    compared to those without diabetes.
    Based on diabetes status and duration of disease and AMI type (STEMI and NSTEMI), logistic and Cox regression analyses were used to estimate the odds ratio (ORs, 95% CI) and hazard ratio (HRs, 95% CI).

    The researchers assembled a cohort that included 29,566 people with diabetes and 109247 people without diabetes
    .
    Adjusted for OR and HR showed that people with diabetes had a significantly higher
    risk of in-hospital mortality (OR 1.
    50, 95% CI 1.
    43 to 1.
    58) and one-year mortality (HR 1.
    51, 95% CI 1.
    46 to 1.
    55) compared with non-diabetic patients 。 These risks gradually increased with the duration of diabetes and were highest in patients with diabetes duration of more than 10 years (in-hospital mortality OR 1.
    59, 95% CI 1.
    50 to 1.
    69, HR 1.
    59, 1-year mortality 95% CI 1.
    53 to 1.
    64).

    These results were similar
    in patients with STEMI and NSTEMI.

    Thus, the study shows that in hospitalized AMI patients, the duration of diabetes is parallel to the risk of death, and it emphasizes that the duration of diabetes should be considered an important early prognostic risk factor
    for AMI patients.

    Original source:

    Marta Baviera.
    et al.
    Diabetes mellitus duration and mortality in patients hospitalized with acute myocardial infarction.
    Cardiovasc Diabetol.
    2022.
    https://cardiab.
    biomedcentral.
    com/articles/10.
    1186/s12933-022-01655-w

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.